COVID-19 Progression in End-Stage Kidney Disease
Completed
- Conditions
- SARS-CoV-2 Infection (Asymptomatic)SARS-CoV-2 Infection (Symptomatic)
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2022-03-22
- Lead Sponsor
- Davita Clinical Research
- Target Recruit Count
- 412
- Registration Number
- NCT04495907
- Locations
- 🇺🇸
DCR Canton, Canton, Ohio, United States
🇺🇸DCR Connecticut, Bridgeport, Connecticut, United States
🇺🇸DCR Victorville, Victorville, California, United States
Registry of Sustained Immunity to COVID-19 Among ESKD Patients
Completed
- Conditions
- Anti-SARS-CoV-2 InfectionSARS-CoV-2 Infection
- First Posted Date
- 2020-08-03
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Davita Clinical Research
- Target Recruit Count
- 2315
- Registration Number
- NCT04495764
- Locations
- 🇺🇸
DCR Canton, Canton, Ohio, United States
🇺🇸DCR El Paso, El Paso, Texas, United States
🇺🇸DCR San Antonio, San Antonio, Texas, United States
Adjuvant Peritoneal Dialysis on a Background of Thrice-Weekly Hemodialysis
Not Applicable
Terminated
- Conditions
- Functionally AnuricHemodialysis/Peritoneal Dialysis
- Interventions
- Other: Adjuvant Peritoneal Dialysis in the context of ongoing Hemodialysis
- First Posted Date
- 2014-01-24
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Davita Clinical Research
- Target Recruit Count
- 1
- Registration Number
- NCT02044614
Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias
Phase 4
Terminated
- Conditions
- Phobic DisordersNeedle Phobia
- Interventions
- Other: Enhanced Needle Phobia InterventionOther: Standard Needle Phobia Intervention
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2016-08-16
- Lead Sponsor
- Davita Clinical Research
- Target Recruit Count
- 10
- Registration Number
- NCT01623583
- Locations
- 🇺🇸
Sunset Dialysis Center, Rancho Cordova, California, United States
🇺🇸Natomas Dialysis, Sacramento, California, United States
🇺🇸Asheville Kidney Center, Asheville, North Carolina, United States
DaVita Assessment of Nutritional Supplement Effects (DANSE)
Phase 4
Completed
- Conditions
- Malnutrition
- Interventions
- Other: Standard of CareDietary Supplement: Nepro with Carb Steady
- First Posted Date
- 2009-05-08
- Last Posted Date
- 2011-02-08
- Lead Sponsor
- Davita Clinical Research
- Target Recruit Count
- 160
- Registration Number
- NCT00895401
- Locations
- 🇺🇸
DaVita, Irvine, California, United States
© Copyright 2025. All Rights Reserved by MedPath